AdvaMed gives the Biden Administration three points to consider as it works with EPA to finalize an updated standard for ethylene oxide emissions from...
A detailed ProPublica analysis says lobbying by several interests killed the inclusion of the VALID act to regulate laboratory-developed tests in the ...
Medical school researchers say most DTC ads are for drugs that do not represent an advance over existing treatments.
FDA warns the South Miami, FL-based Larkin Community Hospital institutional review board about failing to adhere to statutory and regulatory requireme...
After three failed submissions, FDA accepts for review a Fabre-Kramer Pharmaceuticals NDA resubmission for Exxua (gepirone HCl) extended-release table...
Federal Register notice: FDA determines for patent term extension purposes the regulatory review period for Acacia Pharmas Byfavo (remimazolam).
The Service Employees International Union United Healthcare Workers West asks FDA to order five changes to certain Fresenius USA hemodialysis machine...
Five King & Spalding attorneys review the nine advertising and promotion enforcement letters FDA issued in 2022.